Siga Technologies INC Deferred Federal Income Tax Expense (Benefit)
Siga Technologies INC (SIGA) reported Deferred Federal Income Tax Expense (Benefit) of $6.42 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-03-10
- Siga Technologies INC deferred federal income tax expense (benefit) for fiscal 2025 was $6.42M, a 2084.49% increase from fiscal 2024.
- Siga Technologies INC deferred federal income tax expense (benefit) for fiscal 2024 was $294.03K.
- Siga Technologies INC deferred federal income tax expense (benefit) for fiscal 2023 was -$4.71M.
- Siga Technologies INC deferred federal income tax expense (benefit) for fiscal 2022 was -$3.82M, a 4345.04% decline from fiscal 2021.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $6.42M 10-K · filed 2026-03-10 |
| 2024-12-31 | $294.03K 10-K · filed 2026-03-10 |
| 2023-12-31 | -$4.71M 10-K · filed 2026-03-10 |
| 2022-12-31 | -$3.82M 10-K · filed 2025-03-11 |
| 2021-12-31 | $89.95K 10-K · filed 2024-03-12 |
| 2020-12-31 | $11.38M 10-K · filed 2023-03-02 |
| 2019-12-31 | -$2.09M 10-K · filed 2022-03-03 |
| 2018-12-31 | -$9.26M 10-K · filed 2021-03-04 |
| 2017-12-31 | -$2.72M 10-K · filed 2020-03-05 |
| 2016-12-31 | $21.25K 10-K · filed 2019-03-06 |
| 2015-12-31 | $19.01K 10-K · filed 2018-03-06 |
| 2014-12-31 | $53.20M 10-K · filed 2017-03-07 |
| 2013-12-31 | -$10.07M 10-K · filed 2016-03-04 |
| 2012-12-31 | -$7.56M 10-K · filed 2015-03-06 |
| 2011-12-31 | -$35.49M 10-K · filed 2014-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |